Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07659652 · ClinicalTrials.gov registry record
Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease
A clinical trial, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- 200
- Enrollment target
NCT07659652: Clinical Trial study, sponsored by University of California, San Francisco.
NCT07659652 is a clinical trial that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07659652 has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- 200 participants
- Enrollment target
Study Summary
Central nervous system (CNS) metastases including breast cancer brain metastases (BCBMs) and leptomeningeal disease (LMD) are common affecting up to 30% of patients with metastatic breast cancer (MBC). The goal of this research is to understand symptom burden and quality of life trajectories in this population and how treatments guide care management decisions.
Primary Outcome
Participants will complete the 22-item MD Anderson Symptom Inventory for Brain Tumor (MDASI-BT) questionnaire which is designed to capture the severity of various symptoms related to cancer (13 items) and symptoms specifically related to brain cancer (9 items) during the last 24 hours. Participants responses are given on a scale from 0 (not present) to 10 (worst possible). The higher the score the more severe the symptom. A subset of the most prevalent or severe symptoms reported will be used to
Interventions
- OTHER Medical Chart Review
- OTHER Health-Related Quality of Life (QOL) questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2035-12-31 |
What is known before NCT07659652 opens enrollment
NCT07659652 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Medical Chart Review is the first listed.
NCT07659652 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07659652 about?
NCT07659652 is a clinical study titled "Quality of Life for Patients With Breast Cancer Brain Metastases and Leptomeningeal Disease". Central nervous system (CNS) metastases including breast cancer brain metastases (BCBMs) and leptomeningeal disease (LMD) are common affecting up to 30% of patients with metastatic breast cancer (MBC). The goal of this research is to understand symptom burden and quality of life trajectories in this...
What is the current status of trial NCT07659652?
This trial is currently not yet recruiting. The enrollment target is 200 participants. The study started on 2026-06-15. Estimated completion is 2035-12-31.
What interventions are being tested in trial NCT07659652?
The interventions under investigation include: Medical Chart Review (OTHER), Health-Related Quality of Life (QOL) questionnaires (OTHER).
Who is sponsoring clinical trial NCT07659652?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI